Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights - Université de Reims Champagne-Ardenne Access content directly
Journal Articles Marine drugs Year : 2022

Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights

Abstract

Prostate cancer (PCa) is the leading cause of cancer death in men, and its treatment is commonly associated with severe adverse effects. Thus, new treatment modalities are required. In this context, natural compounds have been widely explored for their anti-PCa properties. Aquatic organisms contain numerous potential medications. Anticancer peptides are less toxic to normal cells and provide an efficacious treatment approach via multiple mechanisms, including altered cell viability, apoptosis, cell migration/invasion, suppression of angiogenesis and microtubule balance disturbances. This review sheds light on marine peptides as efficacious and safe therapeutic agents for PCa.
Fichier principal
Vignette du fichier
marinedrugs-20-00466.pdf (1.82 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03756327 , version 1 (22-08-2022)

Licence

Attribution

Identifiers

Cite

Salman Ahmed, Waqas Alam, Philippe Jeandet, Michael Aschner, Khalaf Alsharif, et al.. Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights. Marine drugs, 2022, 20 (8), pp.466. ⟨10.3390/md20080466⟩. ⟨hal-03756327⟩

Collections

URCA RIBP EXEBIO
19 View
20 Download

Altmetric

Share

Gmail Facebook X LinkedIn More